Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Artículo científico |
| Lingua: | en |
| Pubblicazione: |
Centro de investigaciones y Publicaciones Farmacéuticas
2008
|
| Soggetti: | |
| Accesso online: | https://www.redalyc.org/articulo.oa?id=69060202 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
Sommario:
- An economic evaluation of anticipated costs and savings of a behavior change intervention to enhance medication adherence Albert I. Wertheimer Phillip N. Wiegand Medicina Models Psychological United Estates Patient Compliance Costs and Cost Analysis Medication adherence across disease states isgenerally poor. Research has focused on variousmethods to improve medication adherence, butthere is little conclusive evidence regarding specificmethods efficacy. The Transtheoretical Model forBehavior Change has been used to modify existingaddictive behaviors but not in medication adherencespecifically. As a behavioral component is inherentlyrelated to medication adherence, it is thought thatthis model may be applicable.Objective: The purpose of this research is toevaluate the costs and savings of implementing anovel behavioral intervention against the cost ofpoor medication adherence to determine whetherfurther development is realistic.Methods: The basic tools required to administer thisintervention were determined through primaryliterature review and priced by vendors supplyingsuch materials. Diabetes Mellitus Type 2 (DM2) wasused as a vehicle to establish the cost of care forlong-term complications of a chronic disease. Theprimary literature provided information regarding thecost of care for DM2 morbidity and outpatientannual drug therapy expenditure. The total cost ofthe behavioral intervention components and thecost of care for DM2 morbidity were applied to atheoretical cohort of 1000 patients. By dividing thiscost across 1000 patients, a per-patient cost wasyielded and multiplied over a 16-year timeframe.Results: It was found that the cost to implement thebehavioral intervention and resultant medicationcosts is USD13,574 per-patient over 16 years. Thecost to treat complications of diabetes mellitus isUSD 36,528 per patient over the 16 years. The totalamount of healthcare dollars potentially saved byutilizing this intervention is USD 22,954 per-patient.Conclusions: It appears that the cost to implementthis behavioral intervention is reasonable andpermits further evaluation in other chronicconditions with notoriously poor adherence levels 2008 artículo científico 1885-642X https://www.redalyc.org/articulo.oa?id=69060202 en http://www.redalyc.org/revista.oa?id=690 Pharmacy Practice application/pdf Centro de investigaciones y Publicaciones Farmacéuticas Pharmacy Practice (España) Num.2 Vol.6